08/08/2006 - 22:00

Xceed Biotechnology Ltd - 28/07/2006

08/08/2006 - 22:00

Bookmark

Upgrade your subscription to use this feature.

Its 60% owned subsidiary company, PolyNovo Biomaterials Pty Ltd has today signed an agreement with the Monash University Immunology and Stem Cell Laboratories (MISCL). The agreement provides for MISCL to test the utility of NovoSorbâ„¢ as a potential scaffold for stem cells.

This article is only available to our paid subscribers.

To read this article and get full access to every insight Business News offers, subscribe today.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options